Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.

Finzi AA, Latini R, Barlera S, Rossi MG, Ruggeri A, Mezzani A, Favero C, Franzosi MG, Serra D, Lucci D, Bianchini F, Bernasconi R, Maggioni AP, Nicolosi G, Porcu M, Tognoni G, Tavazzi L, Marchioli R.

Am Heart J. 2011 Feb;161(2):338-343.e1. doi: 10.1016/j.ahj.2010.10.032.

PMID:
21315217
2.

n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.

La Rovere MT, Staszewsky L, Barlera S, Maestri R, Mezzani A, Midi P, Marchioli R, Maggioni AP, Tognoni G, Tavazzi L, Latini R; GISSI-HF Investigators.

Heart Rhythm. 2013 Feb;10(2):226-32. doi: 10.1016/j.hrthm.2012.10.035. Epub 2012 Oct 26.

PMID:
23107655
3.

QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure: analysis of Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.

Dobson CP, La Rovere MT, Pinna GD, Goldstein R, Olsen C, Bernardinangeli M, Veniani M, Midi P, Tavazzi L, Haigney M; GISSI-HF Investigators.

Heart Rhythm. 2011 Aug;8(8):1237-42. doi: 10.1016/j.hrthm.2011.03.055. Epub 2011 Mar 30.

PMID:
21457791
4.

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.

Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA); GISSI-Heart Failure (GISSI-HF) Committees and Investigators.

Circulation. 2015 Apr 28;131(17):1486-94; discussion 1494. doi: 10.1161/CIRCULATIONAHA.114.013760. Epub 2015 Mar 25.

PMID:
25810334
5.

Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators.

Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J.

Eur Heart J. 2009 Apr;30(7):820-6. doi: 10.1093/eurheartj/ehp003. Epub 2009 Feb 4. Review.

6.

Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.

Steinberg JS, Beckman K, Greene HL, Marinchak R, Klein RC, Greer SG, Ehlert F, Foster P, Menchavez E, Raitt M, Wathen MS, Morris M, Hallstrom A.

J Cardiovasc Electrophysiol. 2001 Sep;12(9):996-1001.

PMID:
11573709
7.

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.

Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP; AVID Investigators.

J Am Coll Cardiol. 2003 Jul 2;42(1):81-7.

8.

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators.

Circulation. 2004 Mar 23;109(11):1386-91. Epub 2004 Mar 1.

10.

n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators.

Christensen JH, Riahi S, Schmidt EB, Mølgaard H, Kirstein Pedersen A, Heath F, Cosedis Nielsen J, Toft E.

Europace. 2005 Jul;7(4):338-44.

11.

Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.

Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.

Europace. 2008 Mar;10(3):358-63. doi: 10.1093/europace/eun019.

12.
13.

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT; MADIT-II Research Group.

Heart Rhythm. 2007 Nov;4(11):1395-402. Epub 2007 Jul 17.

PMID:
17954398
14.

Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, Friedman PL, Martins J, Ledingham RB, Greene HL; Antiarrhythmics Versus Implantable Defibrillators Investigators.

Am J Cardiol. 2003 Apr 1;91(7):812-6.

PMID:
12667566
15.

N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.

Marchioli R, Silletta MG, Levantesi G, Pioggiarella R, Tognoni G.

Cell Mol Biol (Noisy-le-grand). 2010 Feb 25;56(1):110-30.

PMID:
20196975
16.

Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.

Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J.

JAMA. 2005 Jun 15;293(23):2884-91.

PMID:
15956633
18.

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MA, Akiyama T, Baessler C, Anderson JL.

J Am Coll Cardiol. 1999 Aug;34(2):325-33.

20.

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk